Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn(2B/-) spinal muscular atrophy mice.
- DOI
- 10.1038/s41598-025-24050-3
- Published
- 2025 Nov 17
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-025-24050-3,
title = {Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn(2B/-) spinal muscular atrophy mice.},
author = {Sutton ER and McCallion E and Hoolachan JM and Çetin Ö and Pacheco-Torres P and Rashid S and Bouhmidi S and Haynes K and Churchill L and Scaife T and Chaytow H and Huang YT and Duguez S and Schneider BL and Gillingwater TH and Dimitriadi M and Bowerman M},
year = {2025},
journal = {Scientific reports},
doi = {10.1038/s41598-025-24050-3},
url = {https://doi.org/10.1038/s41598-025-24050-3}
}RIS
TY - JOUR TI - Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn(2B/-) spinal muscular atrophy mice. AU - Sutton ER AU - McCallion E AU - Hoolachan JM AU - Çetin Ö AU - Pacheco-Torres P AU - Rashid S AU - Bouhmidi S AU - Haynes K AU - Churchill L AU - Scaife T AU - Chaytow H AU - Huang YT AU - Duguez S AU - Schneider BL AU - Gillingwater TH AU - Dimitriadi M AU - Bowerman M PY - 2025 JO - Scientific reports DO - 10.1038/s41598-025-24050-3 UR - https://doi.org/10.1038/s41598-025-24050-3 ER -
APA
ER, S., E, M., JM, H., Ö, Ç., P, P., S, R., S, B., K, H., L, C., T, S., H, C., YT, H., S, D., BL, S., TH, G., M, D., & M, B. (2025). Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn(2B/-) spinal muscular atrophy mice.. Scientific reports. https://doi.org/10.1038/s41598-025-24050-3
Source records
- pubmed · retrieved 2026-09-25T18:37:04.245Z